Kratos vs. Rocket Lab: Which Under-the-Radar Defense Stock Will Make You Richer?

Kratos won a $1.45B MACH-TB 2.0 contract and expects hypersonic revenue to roughly double to ~$400M by 2026, while Rocket Lab secured an $816M SDA Tranche 3 prime contract to deliver 18 missile-warning satellites. Rocket Lab is forecast to have 2028 non-GAAP EPS of ~$0.29 (implying ~264x forward multiple) and is currently unprofitable; Kratos is projected to have 2028 EPS of ~$1.34 (~68x) and is currently profitable, giving Kratos a modest valuation and execution edge for risk-tolerant portfolios. Both names are growth-oriented defense plays exposed to drones, hypersonics, and space systems and are best suited to aggressive/speculative investors given lofty multiples.

Analysis

Market pricing currently treats one company as a near-term cash-flow story and the other as a long-dated option on space/sensor upside; that creates a structural dispersion you can exploit. If backlog conversion and defense margin expansion occur on the nearer-term story, the rerating mechanism is straightforward: free cash flow visibility compresses the equity risk premium and drives a rapid multiple expansion within 12–24 months. Conversely, the optionality play requires multiple binary technical and schedule outcomes (vehicle qualification, tranche deliveries), which keeps implied volatility high and downside asymmetry large.

Second-order winners are hardware integrators and domestic optics/manufacturing vendors that can absorb high-cadence build plans without escalating lead times; these suppliers will see order stickiness and better leverage on price. Primes benefit indirectly through modular sourcing — faster, lower-cost subs reduce prime schedule risk but also cap their ability to extract price premium on new architectures, pressuring program-level gross margins over 2–3 years. Watch inventory and labor flows in precision manufacturing: a capacity crunch there would be a choke-point that first manifests as multi-week delays, then as margin erosion for whoever must re-source.

Key catalysts and timelines: expect material re-rating events around sustained flight cadence (next 6–18 months), tranche contract milestones, and FY-end backlog conversion metrics; appropriations and export approvals operate on 12–24 month political cycles and can flip trajectories. Tail risks include single-test failures, export-license friction, or a late-cycle defense-budget pivot—any of which would reprice the optionality-heavy name by 40%+ within weeks. Given these dynamics, capital should be staged: size the option-like exposure smaller, favor controlled structures for the optionality, and use spread strategies to monetize high implied vol while preserving upside optionality.

Key Decisions for Investors

• Pair trade (12–24 months): Long KTOS stock (3–5% portfolio) / Short RKLB equal-dollar (3–5%). Rationale: capture nearer-term earnings visibility and margin expansion vs optionality premium on space execution. Risk: bilateral; set stop-loss at -30% on KTOS leg and -50% on RKLB leg to cap tail risk. Reward: asymmetric — expect 60–120% upside on pair outperformance if backlog converts and Neutron/SDA cadence slips.
• Defined-cost call spread on KTOS (9–18 months): Buy 1x Jan-2027 ITM call, sell a higher strike Jan-2027 call (ratio 1:1) sized for 1–2% portfolio risk. Rationale: levered exposure to margin expansion and contract conversion with capped premium. Risk/Reward: max loss = premium (~100% of allocated), potential 2–4x return if share rerates; reduces Vega exposure vs naked calls.
• Bear put spread on RKLB (6–12 months): Buy moderately OTM put, sell further OTM put to fund ~50–70% of premium. Rationale: expresses downside on execution/valuation risk with defined loss. Risk/Reward: limited downside cost (premium) vs meaningful payoff if key launches or tranche deliveries slip; limit position to <2% portfolio.
• Portfolio hedge (ongoing): Buy small positions in large primes (LMT or NOC) or suppliers (GE) as ballast (2–3% each) to capture program continuity if defense budgets reallocate toward primes; these act as volatility sinks during drawdowns in mid-tier names. Rationale: primes typically compress less on program risk and provide lower-beta exposure to the rearmament cycle.